Final Multivariate Analysis from the Phase 3 MAGNITUDE Study Shows Trend Towards Improvement in Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer with BRCA Alterations Treated with Niraparib and Abiraterone Acetate Plus Pre
Biz Wire Express,
GlobeNewswire 2023-10-22 BEERSE, BELGIUM, Oct. 22, 2023 (GLOBE NEWSWIRE) -- The Janssen Pharmaceutical Companies of Johnson